PCN95 The Cost-Effectiveness of Aprepitant for the Prevention of Nausea and Vomiting Induced by Moderately Emetogenic Chemotherapy in Breast Cancer Patients Compared to Current Clinical Practice in Scotland
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1196
https://www.valueinhealthjournal.com/article/S1098-3015(11)02758-6/fulltext
Title :
PCN95 The Cost-Effectiveness of Aprepitant for the Prevention of Nausea and Vomiting Induced by Moderately Emetogenic Chemotherapy in Breast Cancer Patients Compared to Current Clinical Practice in Scotland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02758-6&doi=10.1016/j.jval.2011.08.1196
First page :
A451
Section Title :
Cancer
Open access? :
No
Section Order :
1153